PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-100.00%
Negative revenue growth is a classic Benjamin Graham warning sign. While possibly cyclical, verify Market Share trends and Competitive Position.
-100.00%
Negative cost of revenue growth (cost reduction) can be positive but verify quality impact. Benjamin Graham would examine if cost cuts are sustainable.
100.00%
Gross profit growth above 25% indicates exceptional core profitability improvement. Warren Buffett would verify pricing power and cost control.
100.00%
Gross margin expansion above 5% indicates exceptional pricing power. Warren Buffett would verify competitive moat strength.
7.04%
R&D growth 5-10% suggests significant investment. Howard Marks would investigate if returns justify increased spending.
-5.63%
Negative G&A growth (overhead reduction) needs verification. Benjamin Graham would examine impact on operations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.59%
Operating expenses growth 0-5% reflects moderate increase. Benjamin Graham would check revenue alignment.
2.59%
Total costs growth 0-3% reflects moderate increase. Benjamin Graham would check revenue alignment.
No Data
No Data available this quarter, please select a different quarter.
13.04%
D&A growth above 10% signals heavy asset expansion. Seth Klarman would demand evidence of future payoff.
-2.44%
Negative EBITDA growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
-2.59%
Negative operating income growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
-15.06%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
-3.66%
Negative pre-tax income growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Tax expense growth above 20% signals concerning expansion. Seth Klarman would scrutinize tax strategy.
-10.34%
Negative net income growth needs thorough analysis. Benjamin Graham would examine operational issues.
No Data
No Data available this quarter, please select a different quarter.
-10.26%
Negative EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
-10.26%
Negative diluted EPS growth needs thorough analysis. Benjamin Graham would examine operational issues.
0.08%
Share increase 0-2% indicates slight dilution. Howard Marks would investigate necessity.
0.08%
Diluted share increase 0-2% indicates slight dilution. Howard Marks would investigate necessity.